Clinical Trial

A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study looks at the effect and safety of a new fast-acting insulin (NNC0471-0119) in people with type 2 diabetes when given by an insulin pump. The study tests how fast insulin NNC0471-0119 enters bloodstream, how long it stays there and how much it lowers blood sugar. The new insulin NNC0471-0119 will be compared to insulin aspart. The study will last for about 13-67 days (or a half to 2 months).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-07; most recent amendment 2026-04-01.
Status change: Recruiting → Completed 2026-04-01
Status change: Not Yet Recruiting → Recruiting 2025-08-28
Trial Details
NCT Number NCT07068295
Lead Sponsor Novo Nordisk A/S
Conditions Diabetes Mellitus, Type 2
Enrollment 65 participants
Start Date 2025-07-11
Primary Completion 2026-02-22 (estimated)
Study Completion 2026-03-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-07